MK0974

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0974, covering 2014-09-08 to 2015-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Two Tablet Forms of MK0974 (0974-045) [Phase 1]